Call for Abstract

2nd International Conference on Hematology & Blood Disorders , will be organized around the theme “On the Path of Identifying Novel Therapeutics for Blood Disorders”

Hematology-2014 is comprised of 10 tracks and 73 sessions designed to offer comprehensive sessions that address current issues in Hematology-2014.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Leukemia
  • Track 1-2Lymphoma
  • Track 1-3Multiple myeloma
  • Track 1-4Biomarkers of blood cancers
  • Track 1-5Molecular diagnosis of hematologic malignancies
  • Track 1-6Targeted therapy for acute leukemia
  • Track 1-7Pallative care in cancer
  • Track 2-1Sickle cell anemia
  • Track 2-2Thalassemia
  • Track 2-3Haemophilia
  • Track 2-4Thrombocytopenia
  • Track 2-5Myelodysplastic syndromes
  • Track 2-6Genetic diseases of the blood
  • Track 2-7Immune mediated hemolytic diseases
  • Track 2-8Hematological disorders of fetus and newborn
  • Track 3-1Umblical cord blood transplantation
  • Track 3-2Bacteremia in blood and marrow transplantation
  • Track 3-3Novel autologus transplantation methods for acute leukemia
  • Track 3-4Unrelated cord blood transplantation
  • Track 3-5Complications after hematopoietic cell transplantation
  • Track 3-6Transmission of diseases and infection via blood transfusion
  • Track 3-7Transfusion medicine
  • Track 4-1Blood group systems
  • Track 4-2B and T-lymphocyte antigen receptors
  • Track 4-3ABO and Rh incompatibility
  • Track 4-4Primary immunodeficiencies
  • Track 4-5Platelet immunology
  • Track 4-6Clinical applications in hematology and immunology
  • Track 4-7Anti-retroviral therapy
  • Track 4-8Flow cytometry
  • Track 4-9Treatment and diagnosis of hematology & immunology related diseases
  • Track 4-10Immunology of Cancer and other blood disorders
  • Track 4-11White blood cells and inflammatory responses
  • Track 5-1 Bio-engineered red blood cell production
  • Track 5-2 Invitro models of transfusion
  • Track 5-3Novel and advanced red blood cell research
  • Track 5-4Human red blood cell alterations
  • Track 5-5Polymorphism
  • Track 5-6Hemoglobin
  • Track 5-7Red blood cell disorders
  • Track 6-1Anticoagulation therapies
  • Track 6-2Chemotherapy- Identifying efficient drug targets
  • Track 6-3Splenectomy
  • Track 6-4Bone marrow transplantation
  • Track 6-5Recombinant proteins and antibodies for treating blood disorders
  • Track 6-6Radiotherapy
  • Track 6-7Cytogenetics in determining cancer
  • Track 6-8Gene therapy
  • Track 6-9Blood parameters for disease diagnosis
  • Track 7-1Thromboembolism
  • Track 7-2Causes of thrombosis
  • Track 7-3Diagnosis and treatment strategies
  • Track 7-4Mechanism of hemostasis
  • Track 7-5Bleeding disorders and hemoglobinopathies
  • Track 7-6Less common congenital disorders of hemostasis
  • Track 7-7Vena cava filters and venous access devices
  • Track 7-8Intravascular coagulation
  • Track 8-1Drug repurposing
  • Track 8-2Approval probabilitites and regulatory review patterns in hematological drugs
  • Track 8-3Clinical hematology
  • Track 8-4Drug induced immune thrombocytopenia
  • Track 8-5Non-steroidal antiinflammatory drugs in the treatment of blood disorders
  • Track 8-6Drug induced blood disorders
  • Track 9-1Hematopoiesis
  • Track 9-2Bone marrow stem cell therapy
  • Track 9-3Novel stem cell transplantation strategies
  • Track 9-4Embryonic and adult stem cell therapy
  • Track 9-5Clinical applications using stem cell
  • Track 10-1Blood disorders & hematopathology in animals
  • Track 10-2Diagnosis, treatment and cure for chronic veterinary disorders
  • Track 10-3Recent therapeutic and diagnostic advancements in animal hematology
  • Track 10-4Animal case studies & reports
  • Track 10-5Immunohematology